BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
KLK3
,
Response to oxidative stress
,
HIV infection
,
Kidney
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
wt1 protein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Gene expression of glomeruli from a mouse model of Denys-Drash syndrome
Wilms tumor gene expression profiles of WT1 and CTNNB1 mutant tumor-derived cell lines
Embryonic fibroblasts overexpressing EWS-WT1 fusion splice variants
Hematopoietic progenitor cells overexpressing WT1-mutant lacking zinc-finger
Colorectal cancer HCT 116 cells cultured in glutamine-free medium
Explore Curated Studies Results
Literature
Most Relevant Literature
Alteration in DNA-binding affinity of Wilms tumor 1 protein due to WT1 genetic variants associated w…
RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular car…
WT1+ glomerular parietal epithelial progenitors promote renal proximal tubule regeneration after sev…
Wilms tumor 1 (WT1) protein: Diagnostic utility in pediatric tumors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study
WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transpla…
A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients
WT1 Peptid Vaccination in Carcinomas
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ